EPI Stock Chart & Stats
AU$0.26
-AU$0.02(-5.45%)
―
--
Day’s Range― - ―
52-Week RangeAU$0.25 - AU$1.49
Previous CloseN/A
VolumeN/A
Average Volume (3M)177.98K
Market Cap
AU$56.33M
Enterprise Value-AU$6.46
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Oct 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding216,671,650
10 Day Avg. Volume157,317
30 Day Avg. Volume177,982
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.23Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.2
Revenue Forecast (FY)N/A
Epiminder Ltd. News
EPI FAQ
What was Epiminder Ltd.’s price range in the past 12 months?
Epiminder Ltd. lowest share price was AU$0.25 and its highest was AU$1.49 in the past 12 months.
What is Epiminder Ltd.’s market cap?
Epiminder Ltd.’s market cap is AU$56.33M.
When is Epiminder Ltd.’s upcoming earnings report date?
Epiminder Ltd.’s upcoming earnings report date is Oct 31, 2026 which is in 31 days.
How were Epiminder Ltd.’s earnings last quarter?
Epiminder Ltd. released its earnings results on Sep 30, 2026. The company reported -AU$0.097 earnings per share for the quarter, missing the consensus estimate of -AU$0.077 by -AU$0.02.
Is Epiminder Ltd. overvalued?
According to Wall Street analysts Epiminder Ltd.’s price is currently Undervalued.
Does Epiminder Ltd. pay dividends?
Epiminder Ltd. does not currently pay dividends.
What is Epiminder Ltd.’s EPS estimate?
Epiminder Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epiminder Ltd. have?
Epiminder Ltd. has 216,671,650 shares outstanding.
What happened to Epiminder Ltd.’s price movement after its last earnings report?
Epiminder Ltd. reported an EPS of -AU$0.097 in its last earnings report, missing expectations of -AU$0.077. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Epiminder Ltd.?
Currently, no hedge funds are holding shares in AU:EPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epiminder Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$2.23 (― Downside)
AU$2.23 (― Downside)
Insider Transactions
Bought Shares
Worth AU$100.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
301.80%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Epiminder Ltd.
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.
EPI Stock 12 Month Forecast
Average Price Target
AU$2.23
Technical Analysis
Uscom Limited
―
Opyl Ltd.
―
Adherium Ltd.
―
InteliCare Holdings Limited
―
PainChek Ltd
―





